Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents.
Appropriate management of polycystic ovary syndrome in adolescents depends on recognizing the syndrome, which can have a variety of presenting complaints and must be differentiated from other causes of hyperandrogenism, as well as not dismissed as "normal adolescence." Oral contraceptives have long been considered the first line of treatment by obstetrician/gynecologists and have many advantages in treating the aspects of PCOS that are most bothersome to teens. Because of the potential risk for cardiovascular disease, early diagnosis and management may be helpful in minimizing the risk of the early metabolic correlates of adult disease.
Hillard
Paula J Adams
PJ
University of Cincinnati College of Medicine, Cincinnati, OH, USA. paula.hillard@cchmc.org
D000293:Adolescent; D003276:Contraceptives, Oral / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000209:etiology*; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*
D003276:Contraceptives, Oral